Promising drug cocktail targets tough pancreatic cancer
NCT ID NCT03415854
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This study tested a combination of three chemotherapy drugs (paclitaxel, cisplatin, gemcitabine) in 34 people with metastatic pancreatic cancer that had not been treated before. If the cancer worsened, a fourth drug (paricalcitol) was added. The goal was to see how well the tumors responded and how long patients lived. The trial is complete, and results help guide future treatment options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HonorHealth Research Institute
Scottsdale, Arizona, 85258, United States
Conditions
Explore the condition pages connected to this study.